HepaStem cell therapy product

	Next higher product group	stem cell therapy_o
	Status	2012-03-28 development p2 pending
	Organisation	Promethera Biosciences S.A.
	Today	Promethera Therapeutics S.A.
	Group	Promethera (Group)

Record changed: 2024-06-07

Picture Berlin Partner Top News Robotics Network Berlin-Brandenburg 650x200px

More documents for HepaStem cell therapy product

[1] Promethera Therapeutics S.A.. (6/30/21). "Press Release: Walloon Company Promethera Announces a €20 Million Financing Round". Mont-Saint-Guibert....
[2] Promethera Biosciences S.A.. (12/16/19). "Press Release: Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D . Total Amount Raise in the Series D Reaches €47.2 Million". Mont-Saint-Guib...
[3] Promethera Biosciences S.A.. (5/7/19). "Press Release: Promethera Biosciences Completes €39.7 Million ($44.4 Million) Series D Financing". Mont-Saint-Guibert & Tokyo....
[4] Promethera Biosciences S.A.. (1/2/19). "Press Release: Promethera Biosciences Announces Investment by Itochu Corporation and a Broad Strategic Collaboration to Access the Asian Markets". Mont-Saint-Guibert & Tokyo....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]